{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:42:26Z","timestamp":1791258146033,"version":"4.1.0"},"reference-count":83,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:p>Vitreoretinal lymphoma (VRL) is a rare ocular malignancy that involves the retina, the retinal pigment epithelium, and the vitreous. It is a subtype of primary central nervous system lymphoma (CNSL). Most cases of VRL and CNSL are classified as diffuse large B-cell lymphoma. Despite its indolent nature, VRL can lead to permanent vision loss and even death due to CNS involvement. The gold standard for diagnosing VRL is the identification of lymphoma cells in a vitreous biopsy. However, diagnosis is challenging due to the rarity and fragility of lymphoma cells. Consequently, various diagnostic methods, such as interleukin level measurement, immunoglobulin clonality assays, flow cytometry, and molecular analysis have been developed to improve diagnostic accuracy. Tools from molecular biology, such as next-generation sequencing and single-cell based analyses, are being investigated as emerging diagnostic modalities. This review aims to discuss the conventional and up-to-date molecular tools for VRL diagnosis and to present important genetic variations and their clinical implications in VRL.<\/jats:p>","DOI":"10.4103\/tjo.tjo-d-24-00052","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T08:00:10Z","timestamp":1735027210000},"page":"236-244","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Molecular diagnosis of vitreoretinal lymphoma"],"prefix":"10.4103","volume":"15","author":[{"given":"Jay Jiyong","family":"Kwak","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, The Institute of Vision Research, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher Seungkyu","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The Institute of Vision Research, Severance Eye Hospital, Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12,24]]},"reference":[{"key":"R1-20250618","doi-asserted-by":"crossref","first-page":"6908","DOI":"10.3390\/curroncol29100543","article-title":"Primary vitreoretinal lymphoma:Current diagnostic laboratory tests and new emerging molecular tools","volume":"29","author":"Melli","year":"2022","journal-title":"Curr Oncol"},{"key":"R2-20250618","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours:Lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"R3-20250618","doi-asserted-by":"crossref","first-page":"101053","DOI":"10.1016\/j.preteyeres.2022.101053","article-title":"Challenges in the diagnosis and management of vitreoretinal lymphoma \u2013Clinical and basic approaches","volume":"90","author":"Takase","year":"2022","journal-title":"Prog Retin Eye Res"},{"key":"R4-20250618","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1080\/09273948.2021.1873394","article-title":"More Accurate diagnosis of vitreoretinal lymphoma using a combination of diagnostic test results:A prospective observational study","volume":"30","author":"Tanaka","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"R5-20250618","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ajo.2021.09.032","article-title":"Vitreoretinal lymphoma:Optimizing diagnostic yield and accuracy","volume":"236","author":"Santos","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"R6-20250618","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/eye.2012.250","article-title":"Intraocular lymphoma:A clinical perspective","volume":"27","author":"Davis","year":"2013","journal-title":"Eye (Lond)"},{"key":"R7-20250618","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10384-012-0150-7","article-title":"Clinical features and diagnostic significance of the intraocular fluid of 217 patients with intraocular lymphoma","volume":"56","author":"Kimura","year":"2012","journal-title":"Jpn J Ophthalmol"},{"key":"R8-20250618","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10384-009-0662-y","article-title":"Diagnosis of intraocular lymphoma by polymerase chain reaction analysis and cytokine profiling of the vitreous fluid","volume":"53","author":"Sugita","year":"2009","journal-title":"Jpn J Ophthalmol"},{"key":"R9-20250618","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.5858\/133.8.1233","article-title":"Intraocular lymphoma:Diagnostic approach and immunophenotypic findings in vitrectomy specimens","volume":"133","author":"Raparia","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"R10-20250618","doi-asserted-by":"crossref","first-page":"611017","DOI":"10.3389\/fmolb.2020.611017","article-title":"Cytologic and molecular diagnostics for vitreoretinal lymphoma:Current approaches and emerging single-cell analyses","volume":"7","author":"Tan","year":"2020","journal-title":"Front Mol Biosci"},{"key":"R11-20250618","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/bjh.14025","article-title":"How we diagnose and treat vitreoretinal lymphoma","volume":"173","author":"Fend","year":"2016","journal-title":"Br J Haematol"},{"key":"R12-20250618","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/09273948.2018.1533984","article-title":"Immunohistochemical and immunocytochemical analyses in patients with vitreoretinal lymphoma","volume":"28","author":"Kase","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"key":"R13-20250618","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.ophtha.2020.01.042","article-title":"Logistic regression classification of primary vitreoretinal lymphoma versus uveitis by interleukin 6 and interleukin 10 levels","volume":"127","author":"Kuo","year":"2020","journal-title":"Ophthalmology"},{"key":"R14-20250618","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40942-018-0120-4","article-title":"The diagnosis and treatment of primary vitreoretinal lymphoma:A review","volume":"4","author":"Pulido","year":"2018","journal-title":"Int J Retina Vitreous"},{"key":"R15-20250618","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.ophtha.2016.01.037","article-title":"ISOLD:A new highly sensitive interleukin score for intraocular lymphoma diagnosis","volume":"123","author":"Costopoulos","year":"2016","journal-title":"Ophthalmology"},{"key":"R16-20250618","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/09273948.2021.1878233","article-title":"Consensus recommendations for the diagnosis of vitreoretinal lymphoma","volume":"29","author":"Carbonell","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"R17-20250618","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1634\/theoncologist.2011-0210","article-title":"Primary vitreoretinal lymphoma:A report from an international primary central nervous system lymphoma collaborative group symposium","volume":"16","author":"Chan","year":"2011","journal-title":"Oncologist"},{"key":"R18-20250618","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/IAE.0000000000002127","article-title":"Differential diagnosis for vitreoretinal lymphoma with vitreoretinal findings, immunoglobulin clonality tests, and interleukin levels","volume":"39","author":"Lee","year":"2019","journal-title":"Retina"},{"key":"R19-20250618","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0161-6420(00)00401-2","article-title":"Interleukin-10 and intraocular-central nervous system lymphoma","volume":"108","author":"Cassoux","year":"2001","journal-title":"Ophthalmology"},{"key":"R20-20250618","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.18240\/ijo.2022.12.01","article-title":"Clinical utility of cytokine analysis in the diagnosis and efficacy monitoring of vitreoretinal lymphoma","volume":"15","author":"Kang","year":"2022","journal-title":"Int J Ophthalmol"},{"key":"R21-20250618","doi-asserted-by":"crossref","first-page":"15992","DOI":"10.1038\/s41598-020-73111-2","article-title":"Serial changes in the aqueous IL-10 level after intravitreal methotrexate injection as an indicator of primary vitreoretinal lymphoma recurrence","volume":"10","author":"Park","year":"2020","journal-title":"Sci Rep"},{"key":"R22-20250618","doi-asserted-by":"crossref","first-page":"955080","DOI":"10.3389\/fonc.2022.955080","article-title":"Circulating cell-free DNA and IL-10 from cerebrospinal fluids aid primary vitreoretinal lymphoma diagnosis","volume":"12","author":"Zhuang","year":"2022","journal-title":"Front Oncol"},{"key":"R23-20250618","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1167\/iovs.64.14.27","article-title":"Next-generation sequencing of vitreoretinal lymphoma by vitreous liquid biopsy:Diagnostic potential and genotype\/phenotype correlation","volume":"64","author":"Kwak","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R24-20250618","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3390\/cancers14030598","article-title":"Diagnosing vitreoretinal lymphomas-an analysis of the sensitivity of existing tools","volume":"14","author":"Sehgal","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R25-20250618","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/dc.24093","article-title":"Flow cytometry immunophenotyping of vitreous specimens does not contribute to diagnosis of lymphoma without supporting morphologic features","volume":"47","author":"Cantu","year":"2019","journal-title":"Diagn Cytopathol"},{"key":"R26-20250618","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0002-9394(14)70828-1","article-title":"Diagnosis of intraocular lymphoma by flow cytometry","volume":"124","author":"Davis","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"R27-20250618","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.ophtha.2012.11.007","article-title":"Multicolor flowcytometric immunophenotyping is a valuable tool for detection of intraocular lymphoma","volume":"120","author":"Missotten","year":"2013","journal-title":"Ophthalmology"},{"key":"R28-20250618","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3390\/curroncol29020065","article-title":"Comprehensive laboratory diagnostic workup for patients with suspected intraocular lymphoma including flow cytometry, molecular genetics and cytopathology","volume":"29","author":"Shumilov","year":"2022","journal-title":"Curr Oncol"},{"key":"R29-20250618","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2174\/1566524013363915","article-title":"Molecular analysis of primary central nervous system and primary intraocular lymphomas","volume":"1","author":"Tuaillon","year":"2001","journal-title":"Curr Mol Med"},{"key":"R30-20250618","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.4049\/jimmunol.176.10.5707","article-title":"TCR trans-rearrangements:Biological significance in antigen recognition versus the role as lymphoma biomarker","volume":"176","author":"Allam","year":"2006","journal-title":"J Immunol"},{"key":"R31-20250618","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00417-004-0890-2","article-title":"Primary intraocular lymphoma of T-cell type:Report of a case and review of the literature","volume":"243","author":"Coupland","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R32-20250618","first-page":"275","article-title":"Molecular pathology of primary intraocular lymphoma","volume":"101","author":"Chan","year":"2003","journal-title":"Trans Am Ophthalmol Soc"},{"key":"R33-20250618","doi-asserted-by":"crossref","first-page":"5684","DOI":"10.3390\/ijms12095684","article-title":"Molecular biomarkers for the diagnosis of primary vitreoretinal lymphoma","volume":"12","author":"Wang","year":"2011","journal-title":"Int J Mol Sci"},{"key":"R34-20250618","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3892\/ijo.2014.2790","article-title":"Diagnostic value of immunoglobulin k light chain gene rearrangement analysis in B-cell lymphomas","volume":"46","author":"Kokovic","year":"2015","journal-title":"Int J Oncol"},{"key":"R35-20250618","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/cncr.21191","article-title":"Analysis of clonal immunoglobulin heavy chain rearrangements in ocular lymphoma","volume":"104","author":"Baehring","year":"2005","journal-title":"Cancer"},{"key":"R36-20250618","doi-asserted-by":"crossref","first-page":"e668","DOI":"10.1111\/aos.14347","article-title":"The importance of cytokines analysis in the diagnosis of vitreoretinal lymphoma","volume":"98","author":"Frenkel","year":"2020","journal-title":"Acta Ophthalmol"},{"key":"R37-20250618","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/icb.2011.31","article-title":"Oncogenic MYD88 mutation drives Toll pathway to lymphoma","volume":"89","author":"Jeelall","year":"2011","journal-title":"Immunol Cell Biol"},{"key":"R38-20250618","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.oret.2022.08.005","article-title":"Aqueous humor-derived MYD88 L265P mutation analysis in vitreoretinal lymphoma:A potential less invasive method for diagnosis and treatment response assessment","volume":"7","author":"Demirci","year":"2023","journal-title":"Ophthalmol Retina"},{"key":"R39-20250618","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature09671","article-title":"Oncogenically active MYD88 mutations in human lymphoma","volume":"470","author":"Ngo","year":"2011","journal-title":"Nature"},{"key":"R40-20250618","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/s41598-017-01998-5","article-title":"Clinicopathologic significance of MYD88 L265P mutation in diffuse large B-cell lymphoma:A meta-analysis","volume":"7","author":"Lee","year":"2017","journal-title":"Sci Rep"},{"key":"R41-20250618","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.4103\/ijo.IJO_1712_19","article-title":"MYD88 L265P mutation in intraocular lymphoma:A potential diagnostic marker","volume":"68","author":"Narasimhan","year":"2020","journal-title":"Indian J Ophthalmol"},{"key":"R42-20250618","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/IAE.0000000000000996","article-title":"Prevalence of myd88 l265p mutation in histologically proven, diffuse large B-cell vitreoretinal lymphoma","volume":"36","author":"Raja","year":"2016","journal-title":"Retina"},{"key":"R43-20250618","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1001\/jamaophthalmol.2018.2887","article-title":"Potential diagnosis of vitreoretinal lymphoma by detection of myd88 mutation in aqueous humor with ultrasensitive droplet digital polymerase chain reaction","volume":"136","author":"Hiemcke-Jiwa","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"R44-20250618","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/IAE.0000000000002319","article-title":"MYD88 L265P mutation detection in the aqueous humor of patients with vitreoretinal lymphoma","volume":"39","author":"Miserocchi","year":"2019","journal-title":"Retina"},{"key":"R45-20250618","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1136\/bjo-2023-324303","article-title":"Anterior segment involvement in vitreoretinal lymphoma:Clinical manifestations, molecular findings and in vivo confocal microscopy","volume":"108","author":"Marchese","year":"2024","journal-title":"Br J Ophthalmol"},{"key":"R46-20250618","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/09273948.2020.1802488","article-title":"Serial detection of MYD88 L265P mutation in the aqueous humor of a patient with vitreoretinal lymphoma for disease monitoring","volume":"29","author":"Choi","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"R47-20250618","doi-asserted-by":"crossref","first-page":"932674","DOI":"10.3389\/fonc.2022.932674","article-title":"Cell-Free DNA sequencing of intraocular fluid as liquid biopsy in the diagnosis of vitreoretinal lymphoma","volume":"12","author":"Gu","year":"2022","journal-title":"Front Oncol"},{"key":"R48-20250618","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.3109\/10428194.2014.979413","article-title":"Primary diffuse large B-cell lymphomas of central nervous system exhibit remarkably high prevalence of oncogenic MYD88 and CD79B mutations","volume":"56","author":"Yamada","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"R49-20250618","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1158\/1078-0432.CCR-14-2116","article-title":"Genome-wide analysis uncovers novel recurrent alterations in primary central nervous system lymphomas","volume":"21","author":"Braggio","year":"2015","journal-title":"Clin Cancer Res"},{"key":"R50-20250618","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1182\/blood-2023-187872","article-title":"Gene panels for intraocular lymphoma can overcome diagnostic difficulties and enable precision medicine","volume":"142","author":"Taoka","year":"2023","journal-title":"Blood"},{"key":"R51-20250618","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.ophtha.2020.11.018","article-title":"Single B-cell genomic analyses differentiate vitreoretinal lymphoma from chronic inflammation","volume":"128","author":"Tan","year":"2021","journal-title":"Ophthalmology"},{"key":"R52-20250618","doi-asserted-by":"crossref","first-page":"102972","DOI":"10.1016\/j.isci.2021.102972","article-title":"Single-cell transcriptome analysis of diffuse large B cells in cerebrospinal fluid of central nervous system lymphoma","volume":"24","author":"Ruan","year":"2021","journal-title":"iScience"},{"key":"R53-20250618","doi-asserted-by":"crossref","first-page":"683007","DOI":"10.3389\/fonc.2021.683007","article-title":"Analysis of cellular heterogeneity in immune microenvironment of primary central nervous system lymphoma by single-cell sequencing","volume":"11","author":"Wei","year":"2021","journal-title":"Front Oncol"},{"key":"R54-20250618","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ceb.2008.01.006","article-title":"Control of protein synthesis and mRNA degradation by microRNAs","volume":"20","author":"Liu","year":"2008","journal-title":"Curr Opin Cell Biol"},{"key":"R55-20250618","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.0307323101","article-title":"Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers","volume":"101","author":"Calin","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R56-20250618","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ajo.2013.12.014","article-title":"Distinct microRNA-155 expression in the vitreous of patients with primary vitreoretinal lymphoma and uveitis","volume":"157","author":"Tuo","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"R57-20250618","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s11060-012-0908-2","article-title":"MicroRNAs in cerebrospinal fluid as biomarker for disease course monitoring in primary central nervous system lymphoma","volume":"109","author":"Baraniskin","year":"2012","journal-title":"J Neurooncol"},{"key":"R58-20250618","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1182\/blood-2017-01-765180","article-title":"Vitreous microRNA levels as diagnostic biomarkers for vitreoretinal lymphoma","volume":"129","author":"Kakkassery","year":"2017","journal-title":"Blood"},{"key":"R59-20250618","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.3390\/jcm9061844","article-title":"High-throughput microrna profiling of vitreoretinal lymphoma:Vitreous and serum MicroRNA Profiles Distinct from Uveitis","volume":"9","author":"Minezaki","year":"2020","journal-title":"J Clin Med"},{"key":"R60-20250618","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.survophthal.2023.12.001","article-title":"Diagnostic methods for primary vitreoretinal lymphoma:A systematic review","volume":"69","author":"Huang","year":"2024","journal-title":"Surv Ophthalmol"},{"key":"R61-20250618","doi-asserted-by":"crossref","first-page":"808511","DOI":"10.3389\/fonc.2022.808511","article-title":"Clinical features, diagnosis, management and prognosis of primary intraocular lymphoma","volume":"12","author":"Zhao","year":"2022","journal-title":"Front Oncol"},{"key":"R62-20250618","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/cac2.12344","article-title":"diagnostic value of genetic mutation analysis and mutation profiling of cell-free DNA in intraocular fluid for vitreoretinal lymphoma","volume":"42","author":"Chen","year":"2022","journal-title":"Cancer Commun (Lond)"},{"key":"R63-20250618","first-page":"1598","article-title":"The molecular hallmarks of primary and secondary vitreoretinal lymphoma","volume":"6","author":"Bonzheim","year":"2022","journal-title":"Blood Adv"},{"key":"R64-20250618","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/cas.14347","article-title":"Gene expression profiling of primary vitreoretinal lymphoma","volume":"111","author":"Arai","year":"2020","journal-title":"Cancer Sci"},{"key":"R65-20250618","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1182\/blood-2015-01-620518","article-title":"High frequency of MYD88 mutations in vitreoretinal B-cell lymphoma:A valuable tool to improve diagnostic yield of vitreous aspirates","volume":"126","author":"Bonzheim","year":"2015","journal-title":"Blood"},{"key":"R66-20250618","doi-asserted-by":"crossref","first-page":"e458","DOI":"10.3324\/haematol.2019.233783","article-title":"Whole exome sequencing identifies mutational signatures of vitreoretinal lymphoma","volume":"105","author":"Lee","year":"2020","journal-title":"Haematologica"},{"key":"R67-20250618","doi-asserted-by":"crossref","first-page":"7989","DOI":"10.18632\/oncotarget.14008","article-title":"Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies:New routes to targeted therapies","volume":"8","author":"Cani","year":"2017","journal-title":"Oncotarget"},{"key":"R68-20250618","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.3324\/haematol.2021.279908","article-title":"Apilot study of the use of dynamic analysis of cell-free DNA from aqueous humor and vitreous fluid for the diagnosis and treatment monitoring of vitreoretinal lymphomas","volume":"107","author":"Wang","year":"2022","journal-title":"Haematologica"},{"key":"R69-20250618","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/ejh.13191","article-title":"CD79B mutations in primary vitreoretinal lymphoma:Diagnostic and prognostic potential","volume":"102","author":"Yonese","year":"2019","journal-title":"Eur J Haematol"},{"key":"R70-20250618","doi-asserted-by":"crossref","first-page":"9992","DOI":"10.3390\/ijms22189992","article-title":"Comparative molecular analysis of primary central nervous system lymphomas and matched vitreoretinal lymphomas by vitreous liquid biopsy","volume":"22","author":"Balikov","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R71-20250618","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/cas.12388","article-title":"High-resolution genomic copy number profiling of primary intraocular lymphoma by single nucleotide polymorphism microarrays","volume":"105","author":"Wang","year":"2014","journal-title":"Cancer Sci"},{"key":"R72-20250618","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"R73-20250618","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pathol.2017.09.006","article-title":"Diffuse large B-cell lymphoma","volume":"50","author":"Li","year":"2018","journal-title":"Pathology"},{"key":"R74-20250618","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1167\/iovs.05-1312","article-title":"Detection of the bcl-2 t (14;18) translocation and proto-oncogene expression in primary intraocular lymphoma","volume":"47","author":"Wallace","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R75-20250618","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N Engl J Med"},{"key":"R76-20250618","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","article-title":"AProbabilistic classification tool for genetic subtypes of diffuse large B Cell lymphoma with therapeutic implications","volume":"37","author":"Wright","year":"2020","journal-title":"Cancer Cell"},{"key":"R78-20250618","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1182\/bloodadvances.2023011213","article-title":"An inducible Cd79b mutation confers ibrutinib sensitivity in mouse models of Myd88-driven diffuse large B-cell lymphoma","volume":"8","author":"Fl\u00fcmann","year":"2024","journal-title":"Blood Adv"},{"key":"R79-20250618","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1053\/j.semdp.2011.04.001","article-title":"Molecular pathogenesis of diffuse large B-cell lymphoma","volume":"28","author":"Schneider","year":"2011","journal-title":"Semin Diagn Pathol"},{"key":"R80-20250618","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.cell.2020.05.049","article-title":"TBL1XR1 mutations drive extranodal lymphoma by inducing a Pro-tumorigenic memory fate","volume":"182","author":"Venturutti","year":"2020","journal-title":"Cell"},{"key":"R81-20250618","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1182\/blood-2022-170569","article-title":"Next-generation sequencing of newly-diagnosed primary CNS lymphoma reveals alterations in BTG1, ETV6, and 6p are associated with chemoresistance and inferior progression-free Survival","volume":"140","author":"Mo","year":"2022","journal-title":"Blood"},{"key":"R82-20250618","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1182\/blood.2020009968","article-title":"Sorting biologic subtypes of primary CNS lymphoma","volume":"137","author":"Roschewski","year":"2021","journal-title":"Blood"},{"key":"R83-20250618","doi-asserted-by":"crossref","first-page":"7116","DOI":"10.1002\/cam4.5512","article-title":"CD79B Y196 mutation is a potent predictive marker for favorable response to R-MPV in primary central nervous system lymphoma","volume":"12","author":"Yamaguchi","year":"2023","journal-title":"Cancer Med"},{"key":"R84-20250618","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1182\/blood.2020008520","article-title":"EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity","volume":"137","author":"Gandhi","year":"2021","journal-title":"Blood"}],"container-title":["Taiwan Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.TJO-D-24-00052","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:24:10Z","timestamp":1787837050000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/tjo.TJO-D-24-00052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,24]]},"references-count":83,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/tjo.tjo-d-24-00052","relation":{},"ISSN":["2211-5056","2211-5072"],"issn-type":[{"value":"2211-5056","type":"print"},{"value":"2211-5072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,24]]},"assertion":[{"value":"2024-05-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}